Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) has shared an update.
Adherium Limited has successfully closed the institutional component of its Accelerated Non-Renounceable Entitlement Offer, raising $4.492 million due to strong demand. The company is poised to enhance its market penetration in the U.S. healthcare sector, leveraging its smart inhaler technology to improve patient care and reduce costs. With commercial agreements in place and plans to expand its patient base, Adherium is set to capitalize on its innovative solutions in respiratory health.
More about Adherium Ltd.
Adherium Limited is a leading digital health company specializing in smart inhaler technology, particularly aimed at improving medication adherence and reducing healthcare costs for asthma and COPD patients. Their Hailie® Smartinhaler technology facilitates real-time remote patient monitoring and is integrated with Medicare-approved billing codes, offering significant financial incentives for healthcare providers.
Average Trading Volume: 99,294
Technical Sentiment Signal: Sell
Current Market Cap: A$5.39M
See more data about ADR stock on TipRanks’ Stock Analysis page.